A single higher-calorie meal is very unlikely to significantly derail your overall progress if the rest of your weekly dietary pattern is well managed, as weight loss is determined by cumulative energy balance over time rather than any one meal
Zepbound shows slightly lower rates of nausea (25% vs 28%) and vomiting (15% vs 17%) compared to Retatrutide
Retrieved from Mishra, R., Raj, R., Elshimy, G., et al
This article will explore the safety of using Wegovy during pregnancy, how the treatment works, available clinical data, and alternative treatment options for weight management
TRIUMPH-1, the main obesity trial, followed 2,339 adults without diabetes for 80 weeks
Understanding the differences between tirzepatide (Zepbound) and semaglutide (Wegovy) is the first step toward determining which path aligns with your biological needs